(Total Views: 402)
Posted On: 08/07/2025 4:29:18 AM
Post# of 155690
Not sure Mr./Ms. Rug's figures are correct. They write:
But I see via https://breast-cancer-research.biomedcentral....hatgpt.com :
Though I have seen studies that show a lower percentage of CCR5-positive tumors in TNBC, I haven't seen a number as low as Mr./Ms. Rug cites. The difference is significant -- does Leron work in 95% of the cases (as one would think based on the small number studied in the collected TNBC cases so far), or does it work in 30 or 40 %?
Quote:
it [Leron] does not work on CCR5 Negative tumors, which should sound obvious but just know that is 30-40% of tumors in the cancer type it is studied, mTNBC
But I see via https://breast-cancer-research.biomedcentral....hatgpt.com :
Quote:
In our prior analysis of over 2200 breast cancer samples, the G protein-coupled receptor CCR5 was expressed in > 95% of TNBC samples.
Though I have seen studies that show a lower percentage of CCR5-positive tumors in TNBC, I haven't seen a number as low as Mr./Ms. Rug cites. The difference is significant -- does Leron work in 95% of the cases (as one would think based on the small number studied in the collected TNBC cases so far), or does it work in 30 or 40 %?
(6)
(1)
